BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 19811091)

  • 1. The CD94/NKG2C-expressing NK cell subset is augmented in chronic lymphocytic leukemia patients with positive human cytomegalovirus serostatus.
    Petersen L; Roug AS; Skovbo A; Thysen AH; Eskelund CW; Hokland ME
    Viral Immunol; 2009 Oct; 22(5):333-7. PubMed ID: 19811091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expansion of CD94/NKG2C
    Puiggros A; Blanco G; Muntasell A; Rodríguez-Rivera M; Nonell L; Altadill M; Puigdecanet E; Arnal M; Calvo X; Gimeno E; Abella E; Abrisqueta P; Bosch F; Yélamos J; Ferrer A; López-Botet M; Espinet B
    Int J Lab Hematol; 2021 Oct; 43(5):1032-1040. PubMed ID: 33615729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children.
    Monsiváis-Urenda A; Noyola-Cherpitel D; Hernández-Salinas A; García-Sepúlveda C; Romo N; Baranda L; López-Botet M; González-Amaro R
    Eur J Immunol; 2010 May; 40(5):1418-27. PubMed ID: 20201038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
    Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection.
    López-Botet M; Muntasell A; Vilches C
    Semin Immunol; 2014 Apr; 26(2):145-51. PubMed ID: 24666761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus.
    Muntasell A; López-Montañés M; Vera A; Heredia G; Romo N; Peñafiel J; Moraru M; Vila J; Vilches C; López-Botet M
    Eur J Immunol; 2013 Dec; 43(12):3268-78. PubMed ID: 24030638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
    Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
    Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction.
    Muntasell A; Vilches C; Angulo A; López-Botet M
    Eur J Immunol; 2013 May; 43(5):1133-41. PubMed ID: 23552990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.
    Gumá M; Cabrera C; Erkizia I; Bofill M; Clotet B; Ruiz L; López-Botet M
    J Infect Dis; 2006 Jul; 194(1):38-41. PubMed ID: 16741880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.
    Rölle A; Pollmann J; Ewen EM; Le VT; Halenius A; Hengel H; Cerwenka A
    J Clin Invest; 2014 Dec; 124(12):5305-16. PubMed ID: 25384219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children.
    Noyola DE; Fortuny C; Muntasell A; Noguera-Julian A; Muñoz-Almagro C; Alarcón A; Juncosa T; Moraru M; Vilches C; López-Botet M
    Eur J Immunol; 2012 Dec; 42(12):3256-66. PubMed ID: 22965785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term exposure to human cytomegalovirus-infected fibroblasts induces a proportional increase of active CD94/NKG2A(+) natural killer cells.
    Petersen L; Petersen CC; Møller-Larsen A; Hokland ME
    Hum Immunol; 2010 Jan; 71(1):29-35. PubMed ID: 19782712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function.
    Sáez-Borderías A; Romo N; Magri G; Gumá M; Angulo A; López-Botet M
    J Immunol; 2009 Jan; 182(2):829-36. PubMed ID: 19124726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease.
    Kordelas L; Steckel NK; Horn PA; Beelen DW; Rebmann V
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
    J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
    Martínez-Rodríguez JE; Cobo-Calvo A; Villar LM; Munteis E; Blanco Y; Rasal R; Vera A; Muntasell A; Alvarez-Lafuente R; Saiz A; Alvarez-Cermeño JC; Martínez-Yélamos S; Roquer J; López-Botet M
    Mult Scler; 2016 May; 22(6):741-52. PubMed ID: 26362897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.